Tissue Banking is Estimated to Witness High Growth Owing to Growing Prevalence of Cancer
![]() |
Tissue Banking Market |
Tissue
Banking refers to the storing of human tissues in tissue banks. Tissue banking
has applications in drug discovery and regenerative medicine. Biospecimen
collection has become critical for advancing medical research in the fields of
cancer, ophthalmology, regenerative medicine and more. Tissue banking provides
researchers access to high-quality, well-characterized normal and diseased
human tissues as well as established cell lines. The global tissue banking
market is estimated to be valued at US$ 1.81 Bn in 2023 and is expected to
exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in
a new report published by Coherent Market Insights.
Market Dynamics:
The Tissue Banking market is expected to witness high growth owing to the
growing prevalence of cancer globally. One in five men and one in six women
worldwide develop cancer during their lifetime, and the economic impact is huge.
Tissue banking plays a crucial role in cancer research by providing
biospecimens to scientists researching cancer causes, progression and
treatments. Availability of such specimens accelerates research and drug
discovery which is otherwise a slow process. This rapid evaluation of new
therapies through tissue banking helps reduce the burden of cancer. The report
projects that the market will be further driven by rising government funding
for regenerative medicine research.
SWOT Analysis
Strength: Tissue banking market has a strong government support in many
countries. R&D investments and technological advancements have improved
quality of life sciences services. Growing demand for regenerative medicine
increases the demand for tissues.
Weakness: High costs associated with establishment and maintenance of tissue
banks pose a challenge. Shortage of skilled professionals and strict regulatory
norms also affect the market's growth. Contamination and improper storage
issues can degrade tissue quality.
Opportunity: Increasing prevalence of chronic and lifestyle diseases creates
scopes for greater adoption. Untapped emerging markets in Asia offer lucrative
opportunities. Stem cell banking sector will drive future growth opportunities.
Threats: Ethical issues surrounding tissue donation and storage may limit
market expansion. Increased competition threatens market share of existing
players. Data privacy and security risks can impact brand value. Stringent
regulatory scrutiny also threatens smooth operations.
Key Takeaways
The Global
Tissue Banking Market Share is expected to witness high growth over the
forecast period of 2023 to 2030, projected to rise at a CAGR of 11%. The market
was valued at US$ 1.81 billion in 2023.
North America currently dominates the global tissue banking market, supported
by advanced healthcare infrastructure and funding for R&D. Asia Pacific
will emerge as the fastest growing region due to rising healthcare expenditure,
growing middle-class population with greater access to services.
Key players operating in the tissue banking market are IBM Corporation, Lucid
Work Incorporation, Microsoft Corporation, Dassault Systems S.A., Oracle Corporation,
X1 Technologies Inc., SAP AG, Coveo Corporation, and Attivio Software
Incorporation. These players are focusing on strategic collaborations and new
product launches to expand their market presence.
For more insights, Read- https://www.pressreleasebulletin.com/tissue-banking-market-trends-size-and-share-analysis/
Comments
Post a Comment